PowerHour Information 03/09/2011.  Background  Description  Vision  Mission  Measurements  Participation Requirements.

Slides:



Advertisements
Similar presentations
University of Minnesota – School of Nursing Spring Research Day Glycemic Control of Critically Ill Patients Lynn Jensen, RN; Jessica Swearingen, BCPS,
Advertisements

Jeffrey A. Johnson, PhD Stephanie U. Vermeulen, MSc. University of Alberta & Institute of Health Economics March 11, 2008.
MODELING METHOD Glucose-Insulin System Model CLINICAL DATA DATA: Are taken from the SPRINT [3] TGC cohort totalling 393 patients and ~40,000 patient hours.
Glycemic Control in Acutely Ill Patients Martin J. Abrahamson, MD FACP Associate Professor of Medicine, Harvard Medical School Senior Vice President for.
2.11 Conduct Medication Management University Medical Center Health System Lubbock, TX Jason Mills, PharmD, RPh Assistant Director of Pharmacy.
CVD Risk Factor Reduction Kelly Moore, MD, FAAP IHS Division of Diabetes Treatment & Prevention.
Facts and Fiction about Type 2 Diabetes Michael L. Parchman, MD Department of Family & Community Medicine September 2004.
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock Dellinger RP, Levy MM, Rhodes A, Annane D, Carcillo JA, Gerlach H,
I CAN Prevent Diabetes! Individuals and Communities Acting Now to Prevent Diabetes Recruitment Discussion 2012.
The Burden of Diabetes 1. Prevalence of Diabetes and Prediabetes in the United States 2 1. CDC. National diabetes fact sheet, 2008.
The Burden of Diabetes.
Source: Site Name and Year IHS Diabetes Audit Diabetes Health Status Report ______Site Name_________ Health Outcomes and Care Given to Patients with Diabetes.
Memorial Hermann Healthcare System Clinical Integration & Disease Management Dan Wolterman April 15, 2010.
4-07 CHANGE IS GOOD: THE BASAL BOLUS INSULIN CONCEPT Management of Hyperglycemia in the Adult Hospitalized Patient: Admission to Discharge TEAM MEMBERS:
Individualizing Targets and Tactics for High- Risk Patients With Type 2 Diabetes Practical lessons from ACCORD and other cardiovascular trials Featured.
INTRODUCTION Stress-induced hyperglycaemia is common in critical care 1 Hyperglycaemia worsens patient outcomes, increasing risk of infection 2, myocardial.
0902CZR01NL537SS0901 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist.
The Patient Undergoing Surgery: Proven Steps to Better Outcomes Ariel U. Spencer, MD Lafayette Surgical Clinic Lafayette, Indiana.
Intensive versus Conventional Glucose Control in Critical Ill Patients N Engl J Med 2009; 360: 雙和醫院 劉慧萍藥師.
Presented by Dr. Soe Sandi Tint
Connected Health: Using patient-centric technologies to change behavior and improve outcomes Joseph C. Kvedar, MD Director Center for Connected Health.

STANDARDS FOR THE PRACTICE RECREATIONAL THERAPY (ATRA, REVISED 2013) HPR 453.
1 NHLBI/NEI National Institutes of Health NHLBI/NEI National Institutes of Health.
Validation of a Virtual Patient and Virtual Trials Method for Accurate Prediction of TGC Protocol Performance F Suhaimi 1,5, A.J. LeCompte 1, S Penning.
Hyperglycemia-Am I A Control Freak? COPYRIGHT © 2013, ALL RIGHTS RESERVED From the Publishers of.
An Innovative Approach to Managing Diabetes in a Large Public Health System Donna J. Calvin, PhD, FNP-BC, CNN Post Doctoral Research Associate University.
Selective vitamin D receptor activation with paricalcitol for reduction of albuminuria in patients with type 2 diabetes (VITAL study) Lambers Heerspink,
Improving Patient Outcomes GLYCEMIC CONTROL IN PERI-OPERATIVE PATIENTS UTILIZING INSULIN INFUSION PROTOCOLS.
Internet-based pilot study comparing low fat with high fat evening snacks in children and adolescents with Type 1 Diabetes using continuous glucose monitoring.
EVALUATION OF CONVENTIONAL V. INTENSIVE BLOOD GLUCOSE CONTROL Glycemic Control in Critically Ill Patients DANELLE BLUME UNIVERSITY OF GEORGIA COLLEGE OF.
Achieving Glycemic Control in the Hospital Setting Part 4 of 4.
Randomized Controlled Trial of Intensive Versus Conservative Glucose Control in Patients Undergoing Coronary Artery Bypass Graft Surgery: GLUCOCABG Trial.
Study Design Scirica BM, Bhatt DL Braunwald et al, Sexagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus. N Engl J Med
Hospital Engagement Network Project and Hospital/System-Level Results for Missouri HEN Participating Hospitals.
Postoperative Glucose Control and SCIP Measures Gorav Ailawadi, MD Chief, Adult Cardiac Surgery University of Virginia April 25, 2015.
Achieving Glycemic Control in the Hospital Setting Part 1 of 3
The Asheville Project “Asheville”.
October 22, 2012 GHA- Glycemic Management Collaborative.
June 23, 2005 “An Employer Driven Incentive Model for Diabetes” Gerald E. Boyd, MD, Medical Director, Employers’ Coalition on Health.
Safety and Efficacy of Sitagliptin Therapy for the Inpatient Management of General Medicine and Surgery Patients With Type 2 Diabetes A pilot, randomized,
PowerHour Information 03/09/2011.  Background  Description  Vision  Mission  Measurements  Participation Requirements.
Achieving Glycemic Control in the Hospital Setting (Part 2 of 4)
1 Challenges and Opportunities In Managing Diabetes and Hyperglycemia Module 2 Diabetes Special Interest Group Georgia Hospital Association.
Credit Valley Hospital Patient Flow Purpose of Initiative To improve the flow of admitted patients from the emergency room to the medical units and improve.
References 1.Buse JB, Ginsberg HN, Bakris GL, et al. Primary prevention of cardiovascular diseases in people with diabetes mellitus: a scientific statement.
Economic Impact Analysis of MyGoalApp Chinyeaka Nwoko Health Economics and Information Systems in Primary Health Care (N8303) Temple University.
World Health Day Objectives Increase awareness about the rise in diabetes, and its staggering burden and consequences, in particular in low- and.
Impact of Intensive Insulin Therapy on Neuromuscular Complications and Ventilator Dependency in the Medical Intensive Care Unit Greet Hermans, Alexander.
Cardiovascular Disease and Antihypertensives The RENAAL Trial Reference Brunner BM, and the RENAAL study group. Effects of losartan on renal and cardiovascular.
Glycemia Treatment Strategies Used In ACCORD
The Burden of Diabetes.
Objective 2 Discuss recent data, guidelines, and counseling points pertaining to the older adults with diabetes.
Reducing Adverse Outcomes after ACS in Patients with Diabetes Goals
The Burden of Diabetes.
Insulin Delivery Systems Atlanta Diabetes Associates
Jessica Lobban, PGY-3 CCLP Family Medicine Residency Program
HOPE: Heart Outcomes Prevention Evaluation study
Patient Safety in Transitions of Care
Neal B, et al. Diabetes Care 2015;38:403–411
Hospital Engagement Network
Surviving Sepsis Campaign Guidelines for Management of Severe Sepsis and Septic Shock Dellinger RP, Levy MM, Rhodes A, Annane D, Carcillo JA, Gerlach.
Diabetes Health Status Report
National Diabetes Strategy
Managing Hypoglycemia & Hyperglycemia
Diabetes econonomy2 Amini Masoud 1397.
The Burden of Diabetes.
Patient flowchart of recruitment and treatment failure and success with glyburide vs. metformin. Patient flowchart of recruitment and treatment failure.
Postoperative blood glucose levels and total insulin requirement.
Cumulative mean numbers of confirmed (plasma glucose ≤3
Presentation transcript:

PowerHour Information 03/09/2011

 Background  Description  Vision  Mission  Measurements  Participation Requirements

 There will be a 230% increase in diabetes cases in our state over the next twenty years. 1  Diabetes costs per year are $5 billion and are expected to increase to almost $12 billion per year.  Currently, new cases of blindness occur at 1000 per year, there are also 1,700 new cases of renal failure and 3,400 lower limb amputations in Georgia alone. These devastating complications are expected to more than double by  Recent studies have shown great improvement in hospitalized patient’s outcomes when blood glucose is closely monitored and managed. 2,3

 Preventing and controlling diabetes and the complications of diabetes are crucial and greatly impacts patient safety.  Standardization of practice will enhance the practitioner’s ability to provide quality care to patients in Georgia.  Using Best Practices will help increase Glycemic Control for patients.

 A free tool available from GHA for hospitals to use for data collection  It is easy to install, transmit data, and run reports for your hospital  Aggregate data will be sent to PHA for analysis for your hospital and across the state  Hospitals can use other resources that help them collect the same data required for the collaboration

 To minimize the frequency of severe hypoglycemic events in Georgia Hospitals  To minimize the frequency of hyperglycemia in Georgia hospitals  To maximize the number of patients achieving euglycemia during hospitalization in Georgia Hospitals  To minimize the frequency of 30-day readmissions due to hyperglycemia

 To improve the overall health outcomes of hospitalized patients with diabetes in the state of Georgia by ◦ tracking outcomes data for the purpose of identifying opportunities for improvement ◦ and demonstrating progress through education and the implementation of evidence-based treatment guidelines that assist hospital staff with the care and treatment of patients with diabetes

 Percent of blood glucose measurement less than 40 mg/dL  Percent of patients whose last blood glucose measurement was greater than 300 mg/dL  Percent of patients with an average mean glucose during hospitalization between 140 mg/DL and 180mg/dL  Number of patients readmitted within 30 days of initial discharge where hyperglycemia is either the primary or secondary discharge

 Submit CEO Commitment Letter and Memorandum of Agreement  Participate in monthly education calls  Submit self–assessment/Action Improvement Plan  Submit quarterly data

 1 Lowley, William, “The Looming Diabetes Crisis in Georgia: What it is now and what it will become by 2025” CDC publication, May,  2 Van den Berghe G, Wouters P, Weekers F, et al. “Intensive insulin therapy in the critically ill patients” N Engl J Med. 2001;345(19):1359–67.Intensive insulin therapy in the critically ill patients”  3 Krinsley, James S, Association Between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population of Critically Ill Patients, From the Division of Critical Care, The Stamford Hospital, Stamford, ConnAssociation Between Hyperglycemia and Increased Hospital Mortality in a Heterogeneous Population of Critically Ill Patients,